Consolidated Statement Of Comprehensive Income

KISSEI PHARMACEUTICAL CO.,LTD. - Filing #7353883

Concept 2023-04-01 to
2023-12-31
2022-04-01 to
2022-12-31
Consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
8,452,000,000 JPY
6,744,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
3,455,000,000 JPY
-8,849,000,000 JPY
Remeasurements of defined benefit plans, net of tax
-210,000,000 JPY
-237,000,000 JPY
Other comprehensive income
3,244,000,000 JPY
-9,086,000,000 JPY
Comprehensive income
11,697,000,000 JPY
-2,342,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
11,570,000,000 JPY
-2,422,000,000 JPY
Comprehensive income attributable to non-controlling interests
126,000,000 JPY
80,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.